openPR Logo
Press release

Oral Mucositis Therapeutics Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years | Top Key Players are Daewoong Pharmaceuticals, Soligenix, Inc., Amgen, Galera Therapeutics, Inc.

06-14-2019 11:24 AM CET | Health & Medicine

Press release from: Pharma Proff

Oral Mucositis Therapeutics Pipeline

Oral Mucositis Therapeutics Pipeline

Oral mucositis is an acute inflammation of the oral mucosa, which is a common side effect of chemotherapy and radiotherapy. The inflammation leads to the formation of ulcers and infections in mouth. It usually occurs in the people with head and neck cancer and lasts for one week to six weeks or more. Lack of nutrition due to inability to eat and severe pain in mouth are some of the problems that occur due to oral mucositis.

Download the sample report at: https://www.pharmaproff.com/request-sample/1243

Other symptoms such as pain, redness or swelling, blood in mouth, white patches, dry mouth, and diarrhea might be observed with the onset of the disease. Several tests including biopsy and fungal testing are used to diagnose oral mucositis. Oral mucositis can be treated by using pain killer medicines, bland rinses, antiseptic mouth rinses, water-soluble lubricating agents, and mucosal coating agents.

Drug such as Kepivance (by Amgen Inc.), a human keratinocyte growth factor, is used for the treatment of oral mucositis.

Get the detailed analysis at: https://www.pharmaproff.com/report/oral-mucositis-therapeutics-pipeline-analysis

According to the research, most of the pipeline drug candidates are being developed for topical administration. It has been found that the topical route is easy to use, non-invasive, and most effective method of administration.
Companies that are involved in developing therapeutics for oral mucositis have shown positive clinical results in various phases of drug development. For instance, Galera Therapeutics Inc.’s drug candidate, GC4419, a small molecule enzyme mimetic that converts superoxide to hydrogen peroxide and molecular oxygen, is being developed for the treatment of oral mucositis. The results from the phase Ib/IIa clinical trial of GC4419 showed that GC4419 was safe and delayed the onset of severe oral mucositis.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1243

In February 2018, the U.S. Food and Drug Administration (USFDA) granted Breakthrough Therapy designation to GC4419 to treat patients with oral mucositis. The Breakthrough Therapy provides intensive USFDA guidance for efficient drug development, and expedites the development and review process of drugs based on supporting clinical data.

Amgen Inc., Galera Therapeutics Inc., Cellceutix Corporation, Daewoong Pharmaceutical Co. Ltd., and Soligenix Inc. are some of the major companies involved in the development of drug candidates for the treatment of oral mucositis.
The report comprises detailed pipeline analysis of therapeutics being developed for the treatment of oral mucositis. Comprehensive insights on the pipeline products have been provided, with special focus on strategic developments of key players, information on drug licensing, designations, financing, and grants, technological advancements, patents, and upcoming conferences. In addition, the report highlights the winning strategies of companies involved in the oral mucositis therapeutics development. Detailed regulatory approval procedures in the U.S., Europe, and Japan are also provided in the report. Furthermore, the report contains competitive analysis and extensive information on monotherapies, combination therapies, targets and mechanisms of action, and drug origin with respect to oral mucositis.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Mucositis Therapeutics Pipeline to Witness Significant Growth due to Positive Clinical Results in the Coming Years | Top Key Players are Daewoong Pharmaceuticals, Soligenix, Inc., Amgen, Galera Therapeutics, Inc. here

News-ID: 1775672 • Views: 872

More Releases from Pharma Proff

Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates. IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates. Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Pate …
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome. Download the sample report at: https://www.pharmaproff.com/request-sample/1189 Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances

All 5 Releases


More Releases for Oral

Global Oral Irrigator Market 2018 - Panasonic, Oral-B, Jetpik, Aquapick
Apex Market Reports, recently published a detailed market research study focused on the “Oral Irrigator Market” across the global, regional and country level. The report provides 360° analysis of “Oral Irrigator Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Oral Irrigator on
Global Oral Care/Oral Hygiene Market Research Report 2017
Latest industry research report on: Global Oral Care/Oral Hygiene Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts The Oral Care/Oral Hygiene Market has been comprehensively detailed in the report with special focus on a range of key elements such as market share, forecast and base figures, CAGR, driving factors, growth restraints, and business opportunities. Buyers of the report are expected to be informed about significant
Oral Care/Oral Hygiene Market Development and Demand Forecast Report
Oral care/oral hygiene is the practice of keeping mouth clean and healthy by regularly brushing and cleaning the teeth. There are several oral problems such as bad breath, dry mouth, canker or cold sores or tooth decay which can be treated with proper diagnosis and oral care. Oral care/oral hygiene market has been growing due to increase in good hygiene practices, increasing prevalence of oral diseases and technological advancements in
Global Oral Care/Oral Hygiene Market Research Report 2017
Report Hive Market Research Released a New Research Report of 128 pages on Title " Global Oral Care/Oral Hygiene Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Oral Care/Oral Hygiene market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report
Global Oral Vaccines Market
The global market for oral vaccines is primarily driven by increasing prevalence of infectious diseases in developing countries, bioterrorism, resistance to existing vaccines, etc. In addition to this, patient adherence to needle-free vaccine regime, preference to oral vaccines by children and geriatric population, cost effective nature, recent FDA approvals to oral vaccines for diseases such as cholera etc. are some of the factors expected to fuel the growth of global
Oral Healthcare Tracker Market grows with oral healthcare technology innovation
Global Oral Healthcare Tracker Market: Overview The global oral healthcare tracker market is currently set to clutch auspicious growth opportunities and affirm broadening expansion with novel and technologically advanced products. For instance, the embedded artificial intelligence (AI) offered with oral health tech company Kolibree’s smart toothbrush has recently made the headlines. According to Kolibree, Ara is the first toothbrush with AI technology. The smart toothbrush is able to record the brushing